- Home
- VATE vs SGMO Comparison
VATE vs SGMO Comparison
Compare VATE & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VATE | SGMO |
|---|---|---|
| Founded | 1994 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.2M | 141.2M |
| IPO Year | 1996 | 2000 |
Fundamental Metrics
Financial Performance| Metric | VATE | SGMO |
|---|---|---|
| Price | $15.28 | $0.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 55.7K | ★ 42.3M |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.20 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,246,000,000.00 | $36,567,000.00 |
| Revenue This Year | N/A | $107.15 |
| Revenue Next Year | N/A | $76.44 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 12.55 | ★ 88.60 |
| 52 Week Low | $3.75 | $0.12 |
| 52 Week High | $16.71 | $0.77 |
Technical Indicators
Market Signals| Indicator | VATE | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 66.82 | 37.98 |
| Support Level | $4.48 | N/A |
| Resistance Level | N/A | $0.55 |
| Average True Range (ATR) | 1.23 | 0.03 |
| MACD | 0.19 | -0.01 |
| Stochastic Oscillator | 77.92 | 34.48 |
Price Performance
Historical ComparisonAbout VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.